NCT06653231

Brief Summary

Smokers usually respond less favourably to non-surgical periodontal treatment compared to non-smokers. Numerous studies reported that smoker patients exhibited less reduction in probing depth and less gains in clinical attachment level values following scaling and root planing (Kanmaz et al., 2021, Alwithanani, 2023) Several studies have proposed the use of adjunctive treatment approaches such as local/systemic antimicrobials and anti-inflammatory agents to improve the effects of basic periodontal therapy in smokers. However, no studies have been published evaluated the conventional management of topically delivered curcumin gel in conjunction with scaling and root planing demonstrating its ability to improve periodontal outcomes in smokers. Meanwhile, some clinical trials indicate that local and systemic administration of curcumin can enhance the results of SRP in periodontal treatment. Local delivery allows higher concentrations of the active compounds in the diseased site and avoids possible adverse effects of systemic administration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Nov 2024

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

October 20, 2024

Last Update Submit

July 15, 2025

Conditions

Keywords

curcuminlocal delivery gelsmokersperiodontitisRCT

Outcome Measures

Primary Outcomes (2)

  • probing pocket depth

    The depth of the pocket will be measured from the gingival margin to the base of the pocket.

    45 days

  • clinical attachment level

    The clinical attachment level will be measured from the CEJ to the base of pocket.

    45 days

Secondary Outcomes (2)

  • gingival index

    45 days

  • Paque index

    45 days

Study Arms (2)

SRP with local delivery of Curcumin gel

EXPERIMENTAL

Scaling and root planing in combination with local delivery of Curcumin gel

Drug: local delivery of Curcumin gel

SRP alone

ACTIVE COMPARATOR

Scaling and root plaing alone

Drug: local delivery of Curcumin gel

Interventions

The test site will be completely undiluted curcumin gel through a 2 mL disposable syringe was placed in the test site

Also known as: turmeric plant Curcuma longa L
SRP aloneSRP with local delivery of Curcumin gel

Eligibility Criteria

Age21 Years - 50 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsage group between 21 and 50 years
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients diagnosed with generalized periodontitis with stage II
  • Nonsurgical or surgical periodontal therapy in the last 3 months were considered as eligible for the study.
  • Current smoker or smoker over the past 5 years.

You may not qualify if:

  • Presence of overhanging restorations,
  • antibiotics or any form of periodontal therapy in the previous 6 months.
  • History of systemic disease, cardiovascular diseases, diabetes mellitus, hypertension, bleeding disorders, hyperparathyroidism, and compromised medical conditions, pregnancy and lactation.
  • Teeth with both endo-perio lesions.
  • Patient on antibiotics within 3 months prior to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MTI University

Cairo, Egypt

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Parryhan M Abdelsamie

    MTI University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of periodontology

Study Record Dates

First Submitted

October 20, 2024

First Posted

October 22, 2024

Study Start

November 1, 2024

Primary Completion

February 1, 2025

Study Completion

March 1, 2025

Last Updated

July 18, 2025

Record last verified: 2025-07

Locations